Tesamorelin
Overview
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), designed to reduce visceral fat. It offers a promising approach for researchers studying HIV-associated lipodystrophy, obesity, and metabolic disorders, with potential applications in fat loss and metabolic health studies. Its targeted action on fat reduction makes it a valuable tool for metabolic research.
Detailed Benefits Analysis
- Fat Reduction: Reduces visceral adipose tissue by stimulating growth hormone secretion. Clinical trials in HIV patients show significant fat loss.
- Metabolic Health: Improves lipid profiles and insulin sensitivity. Studies indicate potential reduction in cardiovascular risk.
- Cognitive Function: May enhance cognitive performance by increasing IGF-1 levels. Research in older adults suggests improved executive function.
- Liver Health: Reduces liver fat and inflammation, supporting liver function. Clinical data show decreased hepatic steatosis.
Important Note
This product is for research purposes only and should not be used for human consumption. It’s not intended to diagnose, treat, or prevent any disease, and always follow local laws when handling research chemicals.
Structure
- Sequence: Trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2
- Molecular Formula: C221H366N72O67S
- Molecular Weight: 5135.89 g/mol
- PubChem CID: 16137821
Loading...